[Abraham, John. 1995. Science, Politics and the Pharmaceutical Industry. London: Routledge.]Search in Google Scholar
[Abraham, John. 2008. “Sociology of pharmaceuticals development and regulation: a realist empirical research programme.” Sociology of Health & Illness 30(6): 869-885.10.1111/j.1467-9566.2008.01101.x]Search in Google Scholar
[Abraham, John. 2009. “The pharmaceutical industry, the state and the NHS.” In The New Sociology of the Health Service, edited by Jonathan Gabe and Michael Calnan, 99-120. London: Routledge.]Search in Google Scholar
[Abraham, John. 2010a. “The Sociological Concomitants of the Pharmaceutical Industry and Medications.” In Handbook of Medical Sociology, edited by Chloe Bird, Peter Conrad, Allen Fremont and Stefan Timmermans, 290-308. Nashville: Vanderbilt University Press.10.2307/j.ctv16h2n9s.20]Search in Google Scholar
[Abraham, John. 2010b. “Pharmaceuticalization of Society in Context: theoretical, empirical, and health dimensions.” Sociology 44(4): 603-622.]Search in Google Scholar
[Ballard, Karen and Mary Ann Elston. 2005. “Medicalisation: A Multidimensional Concept.” Social Theory and Health 3(3): 228-241.10.1057/palgrave.sth.8700053]Search in Google Scholar
[Bell, Susan and Anne E. Figert. 2012. “Medicalization and Pharmaceuticalization at the Intersections: Looking Backward, Sideways and Forward.” Social Science & Medicine 75(5): 775-783.10.1016/j.socscimed.2012.04.002]Search in Google Scholar
[Biehl, João. 2008. “Drugs for all: the Future of Global AIDS Treatment.” Medical Anthropology 27(2): 99-105.10.1080/01459740802022777]Search in Google Scholar
[Busfield, Joan. 2006. “Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry.” Sociology 40(2): 297-314.10.1177/0038038506062034]Search in Google Scholar
[Busfield, Joan. 2010. “‘A Pill for Every Ill’: Explaining the Expansion in Medicine Use.” Social Science & Medicine 70(6): 934-941.10.1016/j.socscimed.2009.10.068]Search in Google Scholar
[Clark, David. 2002. “Between hope and acceptance: the medicalisation of dying.” British Medical Journal 324: 905-907.10.1136/bmj.324.7342.905]Search in Google Scholar
[Clarke, Adele, Janet K. Shim, Laura Mamo, Jennifer Ruth Fosket, and Jennifer R. Fishman. 2003. “Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine.” American Sociological Review 68(2): 161-194.10.2307/1519765]Search in Google Scholar
[Clarke, Adele, Laura Mamo, Jennifer Ruth Fosket, Jennifer R. Fishman, and Janet K. Shim. 2009. Biomedicalization: Technoscience and Transformations of Health and Illness in the U.S. Durham: Duke University Press.10.2307/j.ctv125jk5c]Search in Google Scholar
[Clarke, Adele and Janet Shim. 2009. “Medicalizzazione e biomedicalizzazione rivisitate: tecno-scienze e trasformazioni di salute, malattia e biomedicine.” Salute e Società 2 (Fascicolo EN2): 223-257.]Search in Google Scholar
[Conrad, Peter. 1992. “Medicalisation and Social Control.” Annual Review of Sociology 18: 209-23210.1146/annurev.so.18.080192.001233]Search in Google Scholar
[Conrad, Peter. 2007. The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. Baltimore: Johns Hopkins University Press.]Search in Google Scholar
[Conrad, Peter and Joseph W. Schneider. 1980. “Looking at Levels of Medicalization: A Comment on Strong's Critique of the Thesis of Medical Imperialism.” Social Science & Medicine. Part A: Medical Psychology and Medical Sociology 14(1): 75-79.]Search in Google Scholar
[Conrad, Peter and Joseph W. Schneider. 1992. Deviance and Medicalization: from Badness to Sickness. Philadelphia: Temple University Press.]Search in Google Scholar
[Coveney, Catherine, Jonathan Gabe, and Simon Williams. 2012. “Potenziamento della capacità mentale? Dalla medicalizzazione della cognizione alla farmacologizzazione delle routine mental life”. Salute e Società 2 (Fascicolo suppl. 2): 145-159.10.3280/SES2012-S02010]Search in Google Scholar
[Daemmrich, Arthur. 2004. Pharmaco Politics. Chapel Hill: University of North Carolina.]Search in Google Scholar
[Elliot Carl. 2003. Better Than Well: American Medicine Meets the American Dream. New York: W. W. Norton.]Search in Google Scholar
[Elston, Mary Ann, Jonathan Gabe, David Denney, Raymond Lee, and Maria O'Beirne. 2002. “Violence against Doctors: a Medical(ised) Problem? The Case of National Health Service General Practitioners.” Sociology of Health & Illness 24(5): 575-598.10.1111/1467-9566.00309]Search in Google Scholar
[Fox, Nick and Katie Ward. 2009. “Pharma in the Bedroom and the Kitchen. The Pharmaceuticalisation of Daily Life.” Sociology of Health & Illness 30(6): 856- 868.10.1111/j.1467-9566.2008.01114.x]Search in Google Scholar
[Garattini, Silvio and Vittorio Bertele. 2001. “Adjusting Europe’s Drug Regulation to Public Health Needs.” The Lancet 358(9275): 64-67.10.1016/S0140-6736(00)05258-2]Search in Google Scholar
[Illich, Ivan. 1976. Medical Nemesis. New York: Pantheon; Ital. trans. 2005. Nemesi medica. L’espropriazione della salute. Milano: Boroli Editore.]Search in Google Scholar
[Jones, Kathryn. 2009. “In Whose Interest? Relationships between Health Consumer Groups and the Pharmaceutical Industry in the UK.” In Pharmaceutical and Society: Critical Discourses and Debates, edited by Simon J. Williams, Jonathan Gabe and Peter Davis, 112-125. Oxford: Blackwell.]Search in Google Scholar
[Martin, Paul. 2006. “The Pharmaceutical Person.” BioSocieties 1:.273-287.10.1017/S1745855206003012]Search in Google Scholar
[Metzl, Jonathan and Rebecca Herzig. 2007. “Medicalisation in the 21st Century: Introduction.” The Lancet 369(9562): 697-698.10.1016/S0140-6736(07)60317-1]Search in Google Scholar
[Moynihan, Ray and Richard Smith. 2002. “Too Much Medicine? Almost Certainly.” British Medical Journal 324(7342): 859-860.10.1136/bmj.324.7342.859]Search in Google Scholar
[Nichter, Mark. 1989. “Pharmaceuticals, the Commodification of Health, and the Health Care-medicine Use Transition.” In Anthropology and International Health: Asian Case Studies, edited by Mark Nichter and Mini Nichter, 265-326. Amsterdam: Gordon and Breach Publishers.]Search in Google Scholar
[Novas, Carlos. 2006. “The Political Economy of Hope: Patients’ Organizations, Science and Biovalue.” BioSocieties 1: 289-305.10.1017/S1745855206003024]Search in Google Scholar
[Petryna, Adriana. 2006. “Globalizing Human Subjects Research.” In Global Pharmaceuticals: Ethics, Markets, Practices, edited by Adriana Petryna, Andrew Lakoff, and Arthur Kleinman, 33-60. Durham: Duke University Press.10.2307/j.ctv11cw7qd.5]Search in Google Scholar
[Rodeschini, Giulia. 2012. “Curare gli anziani: pratiche di cura in tensione tra processi assistenziali e di medicalizzazione”. PhD Diss., Università degli Studi di Trento, Scuola di Dottorato in Sociologia e Ricerca Sociale.]Search in Google Scholar
[Rose, Nicholas. 2007. The Politics of Life Itself. Princeton: Princeton University Press.]Search in Google Scholar
[Rossi, Paolo and Mara Tognetti Bordogna. 2013. “Mutual help without borders? Plurality and heterogeneity of online mutual help practices for people with long-term chronic conditions.” The European Journal of Social Work 17(4): 523-538.10.1080/13691457.2013.802225]Search in Google Scholar
[Sironi, Vittorio and Mara Tognetti Bordogna. 2009. “La politique du médicament en Italie: histoire et perspectives.” Revue Sociologie Santé 30: 65-80.]Search in Google Scholar
[Terraneo, Marco, Simone Sarti, and Mara Tognetti Bordogna. 2014. “Social Inequalities and Pharmaceutical Cost Sharing in Italian Regions.” International Journal of Health Services 44(4): 761-785.10.2190/HS.44.4.e]Search in Google Scholar
[Whitmarsh, Ian. 2008. “Biomedical ambivalence: Asthma Diagnosis, the Pharmaceutical and Other Contradictions in Barbados.” American Ethnologist 35(1): 40-63.10.1111/j.1548-1425.2008.00005.x]Search in Google Scholar
[Williams, Simon, Jonathan Gabe, and Peter Davis. 2008. “The sociology of pharmaceuticals: progress and prospects.” Sociology of Health & Illness 30(6): 813-824. 10.1111/j.1467-9566.2008.01123.x]Search in Google Scholar
[Williams, Simon J., Clive Seale, Sharon Boden, Pam Lowe, and Deborah Lynn Steinberg. 2008. “Waking up to sleepiness: Modafinil, the media and the pharmaceuticalisation of everyday/night life.” Sociology of Health & Illness 30(6): 839-855.10.1111/j.1467-9566.2008.01084.x]Search in Google Scholar
[Williams, Simon J. and Paul Martin. 2009. “Correspondence on cognitive enhancement drugs for the healthy: risks and benefits may turn out to be finely balanced.” Nature 457: 532.10.1038/457532a]Search in Google Scholar
[Williams, Simon J., Paul Martin, and Jonathan Gabe. 2011a. “The pharmaceuticalisation of society? A framework for analysis.” Sociology of Health & Illness 33(5): 710-725.10.1111/j.1467-9566.2011.01320.x]Search in Google Scholar
[Williams, Simon J., Paul Martin, and Jonathan Gabe. 2011b. “Evolving sociological analyses of pharmaceuticalisation: a reply to Abraham Sociology of Health & Illness 5: 729-730.10.1111/j.1467-9566.2011.01396.x]Search in Google Scholar
[Williams, Simon J., Jonathan Gabe, and Paul Martin. 2012. “Medicalization and pharmaceuticalization at the intersections: A commentary on Bell and Figert.” Social Science & Medicine 75(12): 2129-2130.10.1016/j.socscimed.2012.08.006]Search in Google Scholar
[Zola, Kenneth. 1972. “Medicine as an Institution of Social Control.” Sociological Review 20(4): 487-504. 10.1111/j.1467-954X.1972.tb00220.x]Search in Google Scholar